These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 23153454

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
    Zhang J, Xi L, Lu C, Li X, Xie T, Zhang H, Xie Z, De Hoog S.
    Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
    [Abstract] [Full Text] [Related]

  • 3. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
    Yang Y, Hu Y, Zhang J, Li X, Lu C, Liang Y, Xi L.
    Med Mycol; 2012 Aug; 50(6):649-53. PubMed ID: 22309458
    [Abstract] [Full Text] [Related]

  • 4. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
    de Andrade TS, de Almeida AMZ, Basano SA, Takagi EH, Szeszs MW, Melhem MSC, Albuquerque M, Camargo JSAA, Gambale W, Camargo LMA.
    Med Mycol; 2020 Feb 01; 58(2):172-180. PubMed ID: 31329924
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
    Carolina Rojas O, León-Cachón RB, Pérez-Maya AA, Aguirre-Garza M, Moreno-Treviño MG, González GM.
    Mycoses; 2015 May 01; 58(5):267-72. PubMed ID: 25728464
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.
    Daboit TC, Magagnin CM, Heidrich D, Castrillón MR, Mendes SD, Vettorato G, Valente P, Scroferneker ML.
    Mycopathologia; 2013 Aug 01; 176(1-2):139-44. PubMed ID: 23645135
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M, Ruíz LF, Castillo A, Arenas R, Vega-Memije ME, Xicohtencatl-Cortes J, Espinoza-Rivera M, Hernández-Castro R.
    J Mycol Med; 2018 Dec 01; 28(4):663-665. PubMed ID: 30126716
    [Abstract] [Full Text] [Related]

  • 12. Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.
    Tan H, Xu Y, Lan XM, Wu YG, Zhou CJ, Yang XC.
    Mycopathologia; 2015 Jun 01; 179(5-6):447-52. PubMed ID: 25575792
    [Abstract] [Full Text] [Related]

  • 13. Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China.
    Xi L, Sun J, Lu C, Liu H, Xie Z, Fukushima K, Takizawa K, Najafzadeh MJ, De Hoog GS.
    Med Mycol; 2009 Feb 01; 47(1):27-33. PubMed ID: 18951291
    [Abstract] [Full Text] [Related]

  • 14. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
    Hu Y, Huang X, Lu S, Hamblin MR, Mylonakis E, Zhang J, Xi L.
    Mycopathologia; 2015 Feb 01; 179(1-2):103-9. PubMed ID: 25366276
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.
    Najafzadeh MJ, Rezusta A, Cameo MI, Zubiri ML, Yus MC, Badali H, Revillo MJ, De Hoog GS.
    Med Mycol; 2010 Mar 01; 48(2):390-3. PubMed ID: 19488919
    [Abstract] [Full Text] [Related]

  • 16. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
    Calvo E, Pastor FJ, Mayayo E, Hernández P, Guarro J.
    Antimicrob Agents Chemother; 2011 Aug 01; 55(8):3709-13. PubMed ID: 21576429
    [Abstract] [Full Text] [Related]

  • 17. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
    Yu J, Li R, Zhang M, Liu L, Wan Z.
    Med Mycol; 2008 Nov 01; 46(7):745-7. PubMed ID: 18608889
    [Abstract] [Full Text] [Related]

  • 18. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
    Hu Y, Qi X, Sun H, Lu Y, Hu Y, Chen X, Liu K, Yang Y, Mao Z, Wu Z, Zhou X.
    PLoS Negl Trop Dis; 2019 Oct 01; 13(10):e0007849. PubMed ID: 31671098
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
    Andrade TS, Castro LG, Nunes RS, Gimenes VM, Cury AE.
    Mycoses; 2004 Jun 01; 47(5-6):216-21. PubMed ID: 15189187
    [Abstract] [Full Text] [Related]

  • 20. A case of chromoblastomycosis by Fonsecaea nubica indicating a possible insect route of transmission.
    Chen Y, Yin S, Li M, Chen R, Wei L, Ma H, Deng S, de Hoog GS, Lai W, Lu C, Feng P.
    Mycoses; 2016 Oct 01; 59(10):662-7. PubMed ID: 27330038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.